# FDA Inspection 575261 - BLI International, Inc. - April 01, 2009

Source: https://www.keypedia.com/records/fda_inspections/bli-international-inc/7b6ea767-c11e-48c0-bf42-3a9c35c93128
Source feed: FDA_Inspections

> FDA Inspection 575261 for BLI International, Inc. on April 01, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 575261
- Company Name: BLI International, Inc.
- Inspection Date: 2009-04-01
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1268782 - 2025-04-11](https://www.keypedia.com/records/fda_inspections/bli-international-inc/d28ae503-5e78-482d-922d-0dcf3ca98fbf)
- [FDA Inspection 1268782 - 2025-04-11](https://www.keypedia.com/records/fda_inspections/bli-international-inc/245d06fd-1014-4043-a60a-3ba416dc4b5a)
- [FDA Inspection 1234201 - 2024-04-24](https://www.keypedia.com/records/fda_inspections/bli-international-inc/c9c3e343-3e7a-4aa6-9929-2402075f799f)
- [FDA Inspection 1095698 - 2019-06-13](https://www.keypedia.com/records/fda_inspections/bli-international-inc/54dcb881-7fb2-4235-82bf-a5e24907a799)
- [FDA Inspection 992510 - 2016-11-02](https://www.keypedia.com/records/fda_inspections/bli-international-inc/99148fbb-82e3-471e-80af-3b38b1002962)

Company: https://www.keypedia.com/companies/bli-international-inc/8a6868ef-5814-4706-b72e-fd228af1b05e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c